1)ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary:A report of the American College Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation);Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 144:700-752, 2006
2)Olshansky B, et al:The Atrial Fibrillation Follow-up Investigation of Rhythm Management Study;Approach to control rate in atrial fibrillation. JACC 43:1201-1208, 2004
3)Van Gelder IC, et al:Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 362:1363-1373, 2010
4)Lechat P, et al:Heart rate and cardiac rhythm relationship with bisoprolol benefit in chronic heart failure in CIBIS Ⅱ trial. Circulation 103:1428-1433, 2001
5)Ogawa S, et al:Optimal treatment strategy for patients with paroxysmal atrial fibrillation. Circ J 73:242-248, 2009
6)Endo A, et al:Impact of drug alteration to maintain rhythm control in paroxysmal atrial fibrillation;Subanalysis from J-RHYTHM study. Circ J 74:870-875, 2010
7)Pappone C, et al:A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation;The APAF study. J Am Coll Cardiol 48:2340-2347, 2006
8)Stabile G, et al:Catheter ablation treatment in patients with drug-refractory atrial fibrillation:A prospective, multi-centre, randomized, controlled study(Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 27:216-221, 2005
9)Wazni OM, et al:Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation;A randomized trial. JAMA 293:2634-2640, 2005
10)Jais P, et al:Catheter ablation versus antiarrhythmic drugs for atrial fibrillation;The A4 study. Circulation 118:2498-2505, 2008